ArticleTherapeutic advances in gastroenterology2024

Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease.

Pilar Navajas Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.